findmyKOL

Steven Flamm, MD

Enriched profile

Professor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College; Director of Research, Section of Hepatology; Clinical Director of Network Development and Outreach, Transplant Service Line, Rush University Medical Center · Rush University Medical Center

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Chicago, IL · Midwest · United StatesSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL type: EliteLatest publication2022Online presenceverified 2026Payments2021–2025NIH funding1998–2004Why? →

Steven Flamm is Professor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College; Director of Research, Section of Hepatology; Clinical Director of Network Development and Outreach, Transplant Service Line, Rush University Medical Center at Rush University Medical Center. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Steven L. Flamm, MD, is Professor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College at Rush University Medical Center / Rush Medical College. The public record shows 259 publications with 14,060 citations (h-index 46), centered on Gastroenterology. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 26 companies, 1 NIH-funded awards (1998–2004).

  • Top research focus: Gastroenterology
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 26 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hepatitis, Autoimmune1 trial

Research focus

OpenAlex concept fingerprint
Gastroenterology

Drugs & molecules

across trials, industry payments and publications
Ocalivageneric · Obeticholic acidClinical trials—Industry payments76Publications—Rezdiffrageneric · ResmetiromClinical trials—Industry payments75Publications—Mavyretgeneric · Glecaprevir / pibrentasvirClinical trials—Industry payments65Publications—Epclusageneric · Sofosbuvir / velpatasvirClinical trials—Industry payments59Publications—Iqirvogeneric · ElafibranorClinical trials—Industry payments48Publications—Livdelzigeneric · SeladelparClinical trials—Industry payments47Publications—Vemlidygeneric · Tenofovir alafenamideClinical trials—Industry payments46Publications—XIFAXANgeneric · RifaximinClinical trials—Industry payments37Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments8Publications—Bylvaygeneric · OdevixibatClinical trials—Industry payments3Publications—Entyviogeneric · VedolizumabClinical trials—Industry payments3Publications—Terlivazgeneric · TerlipressinClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trials—Industry payments241Intercept Pharmaceuticals, Inc.Clinical trials—Industry payments76Madrigal PharmaceuticalsClinical trials—Industry payments76Abbvie Inc.Clinical trials—Industry payments68Ipsen Biopharmaceuticals, IncClinical trials—Industry payments58Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments38Novo Nordisk IncClinical trials—Industry payments18GlaxoSmithKline, LLC.Clinical trials—Industry payments17Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments14Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments2Phathom Pharmaceuticals, Inc.Clinical trials—Industry payments2Albireo Pharma, Inc.Clinical trials—Industry payments1Bausch Health US, LLCClinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Corcept TherapeuticsClinical trials—Industry payments1Echosens North America, Inc.Clinical trials—Industry payments1Janssen Biotech, Inc.Clinical trials—Industry payments1Lilly USA, LLCClinical trials—Industry payments1Mirum Pharmaceuticals, Inc.Clinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1RedHill Biopharma Inc.Clinical trials—Industry payments1Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments1Shionogi IncClinical trials—Industry payments1Veloxis PharmaceuticalsClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
46h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
26companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1998–2004

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    44.7%
    Rifamycin Antibacterial31%
    Xifaxan100%
    Part D≥20 patients
    Bile Acid10.6%
    Ursodiol100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    23.5%
    Loop diuretic12.2%
    Furosemide100%
    Part D≥23 patients
    Aldosterone antagonist (MRA)11.4%
    Spironolactone100%
    Part D≥15 patients
  • Anti-infectives

    17.5%
    Nucleoside and nucleotide reverse transcriptase inhibitors13.2%
    Tenofovir Disoproxil Fumarate74%Vemlidy26%
    Part D<11 patients
    Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor4.2%
    Epclusa100%
    Part D<11 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)22.3% facility · 77.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 1998–2004 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/steven-flamm-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/steven-flamm-128147163

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    rushu.rush.edu/faculty/steven-flamm-md-faasld-facg

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Steven-L-Flamm-39773325

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/SteveFlamm

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    mdnewsline.com/a-conversation-with-transplant-hepatologist-gastroenterologist-dr-steven-flamm

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdnewsline.com ↗
  • Other

    aasld.org/membership/member-resources/member-committees/industry-advancement-committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
  • Other

    rushliverconference.org/faculty-2024

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushliverconference.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile listing title "Transplantation Hepatology - Director of Network Development for Liver Transplantation and Director of Clinical Research"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • Doximity

    Doximity professional profile, Chicago, IL, Gastroenterology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Pennsylvania School of Medicine (Perelman School of Medicine)

    1989
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • Internal Medicine internship and residency

    Beth Israel Hospital, Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • Fellowship

    Gastroenterology, Beth Israel Hospital, Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • Fellowship

    Hepatology and Liver Transplantation, Deaconess Hospital, Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • Board certified

    Gastroenterology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.rush.edu ↗
  • Board certified

    Transplant Hepatology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.rush.edu ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American Association for the Study of Liver Diseases (FAASLD)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
  • Fellow

    American College of Gastroenterology (FACG)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.